Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2025-12-24 @ 5:56 PM
NCT ID:
NCT00862368
Eligibility Criteria:
Inclusion Criteria: In order to be included in the study, participants had to:
* be caregivers for a child (defined as having the child in the home for at least 4 hours per week) between the ages of 3 and 17,
* be current, regular smokers (at least 3 cigarettes per day for the past year)
* be over age 18
* speak and understand English
* have a telephone
* agree to participate in all phases of the study
* have a child with a diagnosis of asthma (asthma groups only)
Exclusion Criteria:
* if the index child had asthma, child DID NOT have a urgent care/emergency room/hospital visit within 90 days of the first intervention visit
* if the index child was healthy, child DID have a urgent care/emergency room/hospital visit within 90 days of the first intervention visit and had no diagnosis of asthma (or other children in the home with asthma)
* had children with other significant pulmonary disease
* the index child spent less than 4 hours in the home per week
* caregiver exclusively used another form of tobacco (not cigarettes)
* using any form of Nicotine replacement therapy
* using medications to quit smoking
* in a quit smoking program
* another member of family is participating in program
* currently pregnant or planning to become pregnant
While we did offer the intervention to all smokers in the home, only the caregiver that spent the most time with the child was included in the formal study.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00862368
Study Brief:
Protocol Section:
NCT00862368